|
Class 2 Device Recall Leica M220 F12 surgical microscope |
|
Date Initiated by Firm |
January 02, 2019 |
Create Date |
January 24, 2019 |
Recall Status1 |
Terminated 3 on April 02, 2021 |
Recall Number |
Z-0772-2019 |
Recall Event ID |
81903 |
Product Classification |
Microscope, operating & accessories, ac-powered, ophthalmic - Product Code HRM
|
Product |
Leica M220 F12 surgical microscope
The Leica M220 F12 surgical microscope is an optical instrument for improving the visibility of objects through magnification and illumination. It can be applied for observation and documentation and for human and veterinary medical treatment. |
Code Information |
Serial Numbers: 10448367-60618002, 10448367-150317002, 10448367-40518001, 10448367-170417002, 10448367-80517001, 10448367-131117001, 10448367-271117001, 10448367-91017002, 10448367-220318003, 10448367-61017001, 10448367-171117001, 10448367-90418001, 10448367-170417001, 10448367-20418001, 10448367-170718002 |
Recalling Firm/ Manufacturer |
Leica Microsystems, Inc. 1700 Leider Ln Buffalo Grove IL 60089-6622
|
For Additional Information Contact |
Philip De Guia 847-291-1125 Ext. 7120
|
Manufacturer Reason for Recall |
The M220 optics may unintentionally drop into the surgical field, risking contact with the patient.
|
FDA Determined Cause 2 |
Process control |
Action |
The firm, Leica, disseminated an "URGENT FIELD SAFETY NOTICE" dated 12/18/2018 on 01/02/2019 to its customers. The notice described the product, problem and actions to be taken. The notice directed the user to inspect the device for a gap between the black adapter and the white housing or a free rotation of the optics carrier for more 360o. If either are noted, the device could not be used.
If you have any questions, contact the Clinical & Scientific Affairs Specialist at 847-876-5705 or email to: Jason.Battle@leica-miosystems.com. |
Quantity in Commerce |
15 units |
Distribution |
Worldwide distribution: US (nationwide) and countries of: Albania, Algeria, Armenia, Argentina, Bangladesh, Brazil, Burundi, Canada, China, Colombia, Egypt, France, Germany, Guatemala, India, Indonesia, Japan, Nepal, Netherlands, New Zealand, Malaysia, Pakistan, Peru, Philippines, Poland, Qatar, Romania, Russia Federation, Saudi Arabia, Senegal, Spain, South Africa, South Korea, Switzerland, Tanzania, Thailand, Turkey, Ukraine, and Vietnam. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|